Active · per the CBE, 17 September 2026

FASE

BE0552649283

Rechtspersoon Private limited company 1 establishment

FASE is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Private Limited, started on 8 May 2014, 1 establishment.

Steenweg 242, 9810 Nazareth-De Pinte

Behind the company: Katrien De Loof, Bart de craene.

Active for

12 year, 4 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 11 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

FASE from Nazareth-De Pinte, company number BE0552649283, closed financial year 2025 with a result of € 33,055 after tax. For that financial year FASE recorded a gross margin of € 117,233 and equity of € 1 million. Compared with financial year 2024, the result moved from € 8,848 to € 33,055. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.

What it is worth Growing

€ 1 million

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 33,055

▲ 274% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 34,484

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,666 paid out

5 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 46,512

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go

€ 987,234

▼ 13% vs 2024

€ 151,041 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 2,220

▼ 87% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 34,444

▲ 92% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 193,233 € 204,722 € 93,411 € 117,233 ▲ 26%
Profit after taxes € 119,060 € 124,028 € 8,848 € 33,055 ▲ 274%
Equity € 871,377 € 993,740 € 1,000,870 € 1,032,259 ▲ 3%
Total debts € 1,611,302 € 1,553,735 € 1,503,912 € 1,414,311 ▼ 6%
Cash € 140,325 € 82,819 € 28,602 € 34,484 ▲ 21%
Retained profit € 671,377 € 793,740 € 800,870 € 832,259 ▲ 4%
Dividend € 1,600 € 1,666 € 1,718 € 1,666 ▼ 3%
Bank debt € 1,307,275 € 1,274,360 € 1,135,234 € 987,234 ▼ 13%
Balance sheet total € 2,482,680 € 2,547,475 € 2,504,783 € 2,446,570 ▼ 2%

Key figures of FASE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FASE?

What happened at FASE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 33,055 (▲ 274% vs 2024). Source: NBB ↗
  • New establishment in Nazareth-De Pinte. KBO
  • Katrien De Loof became a director. NBB
  • Bart de craene became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 119,060 profit in 2022 to € 33,055 profit in 2025.

Paid € 57,920 in corporate taxes since 2022.

Best year ever: 2023, with € 124,028 profit.

Paid out € 6,650 in dividends to the owners in total.

Management

Katrien De Loof
Bart de craene
FASE

Behind FASE are Katrien De Loof and Bart de craene. It owns 100% of Apotheek Gopharma and 99% of Apotheek Pharmago itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Katrien De Loof

Director

Also active at: Wijkgezondheidscentrum Nieuw Gent, APOTHEEK PHARMAGO

since 2014

Bart de craene

Director

Also active at: APOTHEEK GOPHARMA

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg 242

9810 Nazareth-De Pinte

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0552.649.283
VAT number
BE 0552.649.283
Registered office
Steenweg 242, 9810 Nazareth-De Pinte
Names & denominations
FASE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
8 May 2014
Peppol
Active · Active since 27 May 2025
Activities · NACE

Vervaardiging van overige farmaceutische producten

Frequently asked questions

What does FASE do?
FASE is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Private Limited, started on 8 May 2014, 1 establishment.
What is the address of FASE?
The registered office of FASE is located at Steenweg 242, 9810 Nazareth-De Pinte.
Is FASE still active?
Yes. According to the CBE (17 September 2026) FASE is active, legal situation “Normale toestand”, started on 8 May 2014.
Is FASE registered on Peppol?
Yes, FASE is registered on the Peppol network with ID 0208:0552649283.
What is the enterprise number of FASE?
The enterprise number of FASE is BE0552649283.
When was FASE founded?
FASE was founded on 8 May 2014.